Related Experiment Video
Updated: Apr 5, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System
Amit A Somani1, Kirstin Thelen2, Songmao Zheng1
1Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.
Insights
Oral drug absorption in neonates reaches adult levels within one week after birth. This drug-independent maturation function, identified for paracetamol, applies to Biopharmaceutics Classification System (BCS) class I and II drugs.
Area of Science:
- Pharmacokinetics
- Paediatric pharmacotherapy
- Drug absorption
Background:
- Oral drug absorption rates vary in early childhood, with unclear clinical implications, especially for preterm neonates.
- Understanding these changes is crucial for optimizing paediatric drug therapy.
Purpose of the Study:
- To evaluate oral drug absorption changes after birth for Biopharmaceutics Classification System (BCS) class I and II compounds.
- To inform paediatric pharmacotherapy by understanding drug absorption maturation in neonates.
Main Methods:
- Population pharmacokinetic analysis using NONMEM® 7.2.
- Comparative analysis of BCS class I (paracetamol, theophylline) and class II (indomethacin, ibuprofen) compounds.
- Development of an age-dependent maturation function for oral drug absorption.
Main Results:
- Oral drug absorption rate reaches adult levels within approximately one week post-birth.
- A maturation function developed for paracetamol was applicable to theophylline and indomethacin, considering formulation-based solubility.
- Excipient influence on solubility and bioavailability was confirmed for ibuprofen.
Conclusions:
- Postnatal oral drug absorption changes are drug-independent.
- The identified maturation function for paracetamol is likely generalizable to other BCS class I and II drugs.
- This aids in characterizing drug absorption in both preterm and term neonates.
Aims:
Evidence suggests that the rate of oral drug absorption changes during early childhood. Yet, respective clinical implications are currently unclear, particularly for preterm neonates. The objective of this study was to evaluate changes in oral drug absorption after birth for different Biopharmaceutics Classification System (BCS) class I and II compounds to better understand respective implications for paediatric pharmacotherapy.
Methods:
Two paradigm compounds were selected for BCS class I (paracetamol (acetaminophen) and theophylline) and II (indomethacin and ibuprofen), respectively, based on the availability of clinical literature data following intravenous and oral dosing. A comparative population pharmacokinetic analysis was performed in a step-wise manner in NONMEM® 7.2 to characterize and predict changes in oral drug absorption after birth for paracetamol, theophylline and indomethacin.
Results:
A one compartment model with an age-dependent maturation function for oral drug absorption was found appropriate to characterize the pharmacokinetics of paracetamol. Our findings indicate that the rate at which a drug is absorbed from the GI tract reaches adult levels within about 1 week after birth. The maturation function for paracetamol was found applicable to theophylline and indomethacin once solubility limitations were overcome via drug formulation. The influence of excipients on solubility and, hence, oral bioavailability was confirmed for ibuprofen, a second BCS class II compound.
Conclusions:
The findings of our study suggest that the processes underlying changes in oral drug absorption after birth are drug-independent and that the maturation function identified for paracetamol may be generally applicable to other BCS class I and II compounds for characterizing drug absorption in preterm as well as term neonates.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Influencing Drug Absorption: Drug Dissolution

